Arimidex 1mg tablet is an anticancer drug with the ingredient Anastrozole. It belongs to the medication class known as aromatase inhibitors. The Arimidex tablet is used to treat hormone-dependent breast cancer in postmenopausal women. Aromatase inhibitors reduce estrogen levels by preventing an enzyme in adipose tissue from converting other hormones into estrogen. This medication helps to delay the recurrence of early-stage breast cancer.
The common side effects are nausea, vomiting, loss of appetite, fever, itching, inflammation of the joints (arthritis), bone loss (osteoporosis), bleeding from the vagina, hypersensitivity, and joint, stomach, and kidney pain.
If you are allergic to Anastrozole or its ingredients, tell your doctor before starting treatment with this medication. Tell your doctor if you are still experiencing menstruation and have not yet reached menopause, have osteoporosis, or have any liver or kidney problems. If you are lactose intolerant, consult your doctor before taking this medicine. Do not take medicine if you are pregnant or breastfeeding.
What is Arimidex 1mg and why is it used? Arimidex 1mg is an anticancer drug with the ingredient, Anastrozole, the ingredient, and the purpose is to treat hormone-dependent breast cancer in postmenopausal women. It has the disadvantage of being taken orally, but there are many other uses for Arimidex 1mg that you may not have heard of. You may take it with or without meals.Arimidex 1mg is taken by mouth once every 24 hours, with or without food. The dose may be taken as low as 2.5 mg/24h. The benefits of Arimidex 1mg over other anticancer drugs likeolanzapineare that it can be taken continuously at a dose of 1 mg/day without affecting other medicines. However, there are side effects with Arimidex 1mg that may require dose adjustments or withdrawal from the medication.
Arimidex 1mg Storage Cautions Arimidex 1mg is taken with or without food. It should not be taken more than once a day. Arimidex 1mg may cause side effects like breast tenderness, headache, nausea, dizziness, and dark urine.Keep the medicine out of reach of children. Store it at room temperature between 15 and 30 degrees C (59 and 86 degrees F).
Arimidex 1mg Warnings Tell your doctor if you have any of these conditions: * you are allergic to any of the ingredients in Arimidex 1mg * you are pregnant * you are breastfeeding * you are taking nitrate-based medications like isosorbide, isosorbide mononitrate, or nitroglycerin. Do not take Arimidex 1mg if you are taking nitrate-based medications. * you are taking any medications for diabetes, including,,,,,,,,,, and. If you take any of these medications, tell your doctor before taking Arimidex 1mg because they can cause serious side effects. * you are taking any herbal supplements or products that contain epimabine or. Tell your doctor if you are taking or have recently taken any other medicines. Medicines that interact with Arimidex 1mg may affect how well the medication works. For example, if your doctor prescribes Arimidex 1mg as first-line therapy for, you may not experience any changes in your condition.Tell your doctor if you are taking or have recently taken any of the following medicines: * any hormone replacement therapy, including. * oral contraceptives *,, or * (a type of hormonal birth control called.)
Arimidex Side Effects Side effects with Arimidex 1mg are similar to those with other anticancer medications like. However, they can vary in terms of intensity and frequency. Most of the side effects of Arimidex 1mg are mild and do not require medical attention. For example, in rare cases, Arimidex 1mg can cause liver problems, a condition in which the liver is unable to produce a high level of estrogen. This makes it difficult to achieve and maintain an adequate estrogen level.This medication is taken by a doctor who can check your blood pressure and tell you if there is an allergic reaction.
The tablets are used by the body to stop cancer and other blood clots from coming back, and by the liver, which helps it absorb the medicine.
This medicine is used to treat the symptoms of a blood clots.
The drug is also used to prevent breast cancer.
It is also used to reduce the risk of cancer in women who are over 50. This medicine is available only with a doctor’s prescription.
There is not enough information to make a full list of side effects.
If you are concerned about side effects, speak with your doctor or pharmacist.
Get medical help right away if you have any of the following side effects:
Common side effects may include:
If you experience any side effects, talk to your doctor or pharmacist.
If you experience any side effects that you think are not listed above, contact your doctor or pharmacist.
You should not have a blood test if you are pregnant or breastfeeding, or if you have allergies to a drug or a medicine you take.
If you get any side effects while taking this medication, talk to your doctor or pharmacist.
If you take the drug in small doses, do not break it open or crush it, or mix it with food or drink, do not take it with dairy products, calcium supplements, or potassium supplements, or take it with other medicines you take. This could increase the risk of side effects.
This product is a Prescription Only Medicine (S4) and is sold by Healthylife Pharmacy, an independently owned and operated pharmacy business. This prescription product requires a valid Australian script.
This product is temporarily unavailable.
Healthylife provides general product information such as nutritional information, country of origin and product packaging for your convenience. This information is intended as a guide only, including because products change from time to time. Please read product labels before consuming. For therapeutic goods, always read the label and follow the directions for use on pack. If you require specific information to assist with your purchasing decision, we recommend that you contact the manufacturer via the contact details on the packaging or email us at [email protected]. Product ratings and reviews are taken from various sources including Bazaarvoice. Healthylife does not represent or warrant the accuracy of any statements, claims or opinions made in product ratings and reviews.
Product(s) on Healthylife website ( worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen - worsen (1) the importance of mammograms for general practitioners and their patients; and; and; and (2) the need for mammograms for general practitioners and general practitioners' patients with unexplained infertility, unexplained female partner failure and unexplained male infertility.Arimidex Aromatase Inhibitor (Anastrozole) and its generic version, Arimidex (anastrozole) are both FDA-approved medications designed to treat hormone receptor-positive breast cancer in postmenopausal women. Arimidex (anastrozole) is primarily used for the treatment of metastatic breast cancer, while Arimidex (anastrozole) is approved for the adjuvant treatment of hormone receptor-positive early breast cancer.
Anastrozole works by inhibiting the aromatase enzyme, which converts androgens (male hormones) into estrogen. This conversion is crucial for maintaining and improving the body’s estrogen level. Anastrozole is a selective inhibitor of the aromatase enzyme, with high affinity and specificity for androgen receptors, thereby inhibiting estrogen-stimulated mini-cycle and postmenopausal estrogen receptor (ER)-positive breast cancer.
Anastrozole was first approved for the adjuvant treatment of hormone receptor-positive early breast cancer in the United States in 1967. Its use was later expanded to other hormone receptor types, including ER-positive, ER-unknown, and ER-negative breast cancer in the 1990s.
Anastrozole is available in several doses, including:
In clinical trials, anastrozole demonstrated superior survival rates compared to adjuvant-only therapy in postmenopausal women with hormone receptor-positive breast cancer (30–45% versus 5–6%, respectively). In addition to its adjuvant use, Anastrozole was also approved for the adjuvant treatment of locally advanced or metastatic breast cancer in postmenopausal women, with a higher rate of complete response and better survival compared to adjuvant treatment alone.
Anastrozole blocks the effects of aromatase, thereby inhibiting estrogen-stimulated mini-cycle and postmenopausal estrogen receptor (ER)-positive breast cancer.
Anastrozole does not directly affect estrogen-responsive tumors. Rather, it reduces the negative effects of estrogen on tumor growth, which often leads to more favorable outcomes.
Additionally, anastrozole can significantly reduce the risk of developing multiple types of breast cancer, such as ER-positive, ER-unknown, and ER-negative breast cancer. It is particularly beneficial for postmenopausal women with hormone receptor-positive early breast cancer, as it reduces the risk of developing these cancers.
Overall, anastrozole is an effective treatment for hormone receptor-positive breast cancer, while Arimidex (anastrozole) is effective for the adjuvant treatment of hormone receptor-positive early breast cancer.
Anastrozole is approved for the adjuvant treatment of hormone receptor-positive early breast cancer in postmenopausal women with metastatic disease or locally advanced or metastatic breast cancer. It was also approved for the adjuvant treatment of locally advanced or metastatic breast cancer in postmenopausal women after initial initial treatment and after surgery.
While anastrozole has shown positive results in postmenopausal women with metastatic breast cancer, Arimidex (anastrozole) has not yet been approved for the treatment of hormone receptor-positive early breast cancer.
While Anastrozole has shown promising results in the adjuvant treatment of hormone receptor-positive early breast cancer, it is not as effective as Arimidex in adjuvant therapy. Anastrozole has not yet shown promising results in adjuvant therapy, although it may be prescribed for postmenopausal women with hormone receptor-positive early breast cancer.
Despite its effectiveness, Anastrozole still has potential side effects.
Stade de France Pharmacy